SCHEMBL3687294

SCHEMBL3687294

Cn1cc(-c2ccc(S(=O)(=O)Cl)s2)c(C(F)(F)F)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
PRMT5 O14744 1/20 0.37
WDR77 Q9BQA1 1/20 0.37
L3MBTL1 Q9Y468 3/20 0.36
GAA P10253 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP3A4 P08684 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
GCK P35557 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALDH1A1 P00352 1/20 0.35
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3010846 0.72 GAA (0.64) NPC1RAB9AL3MBTL1GAAPOLB
SCHEMBL3019078 0.71 RAB9A (0.77) NPC1RAB9AL3MBTL1GAALMNA
SCHEMBL391271 0.70 POLB (0.40) L3MBTL1GAACYP2C19CYP3A4LMNA
SCHEMBL3255501 0.69 ALDH1A1 (0.55) ALDH1A1CA12CA1CA2CA9
SCHEMBL7147449 0.68 L3MBTL1 (0.48) NPC1RAB9AL3MBTL1GAALMNA
SCHEMBL4880604 0.68 NPC1 (0.36) NPC1RAB9AL3MBTL1GAAPOLB
SCHEMBL7519394 0.68 NPC1 (0.33) NPC1RAB9AL3MBTL1GAA
SCHEMBL17437098 0.65 POLB (0.51) PRMT5WDR77L3MBTL1GAACYP2C19
SCHEMBL3253299 0.65 KIF11 (0.42) GCKCA12CA1CA2CA9
SCHEMBL7347511 0.65 KIF11 (0.42) GCKCA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7655641-B2 Sulfonamide derivatives as PPAR modulators ELI LILLY AND COMPANY (US) 2010-02-02 US disclosed
EP-1597248-B1 SULFONAMIDE DERIVATIVES AS PPAR MODULATORS LILLY CO ELI (US) 2007-12-26 EP disclosed
US-20060217433-A1 Sulfonamide derivatives as ppar modulators ELI LILLY AND COMPANY (US) 2006-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217433-A1 Sulfonamide derivatives as ppar modulators PPARD, PPARA, PPARG NPC1 963/4885RAB9A 4008/4885PRMT5 2643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.